Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants

Chia Chung Hou, Chun Houh Chen, Ning Sun Yang, Yi Ping Chen, Chiu Ping Lo, Sheng Yang Wang, Yin Jing Tien, Pi Wen Tsai, Lie Fen Shyur

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2. E,4. E,8. Z,10. Z(E)-tetraenoic acid isobutylamides (8/. 9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.

Original languageEnglish
Pages (from-to)1045-1059
Number of pages15
JournalJournal of Nutritional Biochemistry
Volume21
Issue number11
DOIs
Publication statusPublished - Nov 2010
Externally publishedYes

Fingerprint

Echinacea
Metabolomics
Cyclooxygenase 2
Metabolites
Bioactivity
Mass spectrometry
Assays
Anti-Inflammatory Agents
Genes
Rutin
Heme Oxygenase-1
Supercritical fluids
Macrophages
High performance liquid chromatography
Nitric Oxide Synthase Type II
Interleukin-1
Mitogens
Chemokines
Gas chromatography
Medicine

Keywords

  • Alkamides
  • Anti-inflammation
  • Echinacea
  • Metabolomics

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants. / Hou, Chia Chung; Chen, Chun Houh; Yang, Ning Sun; Chen, Yi Ping; Lo, Chiu Ping; Wang, Sheng Yang; Tien, Yin Jing; Tsai, Pi Wen; Shyur, Lie Fen.

In: Journal of Nutritional Biochemistry, Vol. 21, No. 11, 11.2010, p. 1045-1059.

Research output: Contribution to journalArticle

Hou, Chia Chung ; Chen, Chun Houh ; Yang, Ning Sun ; Chen, Yi Ping ; Lo, Chiu Ping ; Wang, Sheng Yang ; Tien, Yin Jing ; Tsai, Pi Wen ; Shyur, Lie Fen. / Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants. In: Journal of Nutritional Biochemistry. 2010 ; Vol. 21, No. 11. pp. 1045-1059.
@article{5bcf823b4ecb4d79821ae9be94658b6a,
title = "Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants",
abstract = "Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2. E,4. E,8. Z,10. Z(E)-tetraenoic acid isobutylamides (8/. 9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.",
keywords = "Alkamides, Anti-inflammation, Echinacea, Metabolomics",
author = "Hou, {Chia Chung} and Chen, {Chun Houh} and Yang, {Ning Sun} and Chen, {Yi Ping} and Lo, {Chiu Ping} and Wang, {Sheng Yang} and Tien, {Yin Jing} and Tsai, {Pi Wen} and Shyur, {Lie Fen}",
year = "2010",
month = "11",
doi = "10.1016/j.jnutbio.2009.08.010",
language = "English",
volume = "21",
pages = "1045--1059",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants

AU - Hou, Chia Chung

AU - Chen, Chun Houh

AU - Yang, Ning Sun

AU - Chen, Yi Ping

AU - Lo, Chiu Ping

AU - Wang, Sheng Yang

AU - Tien, Yin Jing

AU - Tsai, Pi Wen

AU - Shyur, Lie Fen

PY - 2010/11

Y1 - 2010/11

N2 - Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2. E,4. E,8. Z,10. Z(E)-tetraenoic acid isobutylamides (8/. 9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.

AB - Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2. E,4. E,8. Z,10. Z(E)-tetraenoic acid isobutylamides (8/. 9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.

KW - Alkamides

KW - Anti-inflammation

KW - Echinacea

KW - Metabolomics

UR - http://www.scopus.com/inward/record.url?scp=77958150812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958150812&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2009.08.010

DO - 10.1016/j.jnutbio.2009.08.010

M3 - Article

VL - 21

SP - 1045

EP - 1059

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 11

ER -